Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06089083 · ClinicalTrials.gov registry record
PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery
A clinical trial of Gynecologic Cancer and Malignant Female Reproductive System Neoplasm, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT06089083 is a study of Gynecologic Cancer and Malignant Female Reproductive System Neoplasm that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 500 participants, below the 755-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (34% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06089083, a study of Gynecologic Cancer and Malignant Female Reproductive System Neoplasm, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
Conditions Studied
Interventions
- OTHER Physical function assessment
- OTHER Self-reported Assessments and Questionnaires
- PROCEDURE Surgery (Standard of Care, Non-Interventional)
Study Locations (2)
California
- University of California, San Francisco - San Francisco
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-10-18 |
| Est. Completion | 2033-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06089083
The ClinicalTrials.gov registry entry for NCT06089083 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 755-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (34% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 3 interventions - of which Physical function assessment is the first listed.
NCT06089083 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06089083 about?
NCT06089083 is a clinical study titled "PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery". This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.
What is the current status of trial NCT06089083?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-10-18. Estimated completion is 2033-11-30.
What conditions does trial NCT06089083 study?
This clinical trial studies the following conditions: Gynecologic Cancer, Malignant Female Reproductive System Neoplasm, Gynecologic Neoplasm.
What interventions are being tested in trial NCT06089083?
The interventions under investigation include: Physical function assessment (OTHER), Self-reported Assessments and Questionnaires (OTHER), Surgery (Standard of Care, Non-Interventional) (PROCEDURE).
Who is sponsoring clinical trial NCT06089083?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06089083 being conducted?
This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
Explore more on PlainTrial
Gynecologic Cancer
All registered trials for this condition
Malignant Female Reproductive System Neoplasm
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.